A5084443330- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac pacing and defibrillation studies
- Health Systems, Economic Evaluations, Quality of Life
- Atrial Fibrillation Management and Outcomes
- Cardiac Structural Anomalies and Repair
- Cardiac Imaging and Diagnostics
- Erythropoietin and Anemia Treatment
- Frailty in Older Adults
- Iron Metabolism and Disorders
- Cardiac Arrhythmias and Treatments
- Venous Thromboembolism Diagnosis and Management
- Heart Failure Treatment and Management
Bellvitge University Hospital
2020-2023
Institut d'Investigació Biomédica de Bellvitge
2022-2023
The effects of iron deficiency (ID) have been widely studied in heart failure (HF) with reduced ejection fraction. On the other hand, studies HF preserved fraction (HFpEF) are few and included small numbers participants. aim this study was to assess role that ID plays functional capacity quality life (QoL) HFpEF while comparing several iron-related biomarkers be used as potential predictors. defined ferritin <100 ng/mL or transferrin saturation <20%. Submaximal exercise capacity,...
Clinical practice guidelines recommend extending dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome (ACS) in patients with high ischemic risk and without bleeding risk. The aim of this study was to identify variables associated DAPT prolongation a cohort 1967 consecutive discharged ACS thrombotic or hemorrhagic events during the following year. sample stratified according whether extended year, factors strategy were analyzed. In 32.2% patients, Overall, 770 (39.1%)...
Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk ischaemia low bleeding. No data exist about implementation this strategy older adults from routine clinical practice.We conducted Spanish multicentre, retrospective, observational registry-based study that included ACS but no thrombotic or bleeding events during first DAPT after discharge indication for oral anticoagulants. High...